Table 6 Average individual level health gain associated with five-years of double therapy with (3%) and without (0%) discounting to potentially facilitate more informed patient-clinician discussions around medication use (the values at 0% discount rate are in brackets)
Five-year cumulative absolute risk strata | Quality-adjusted healthy months of life gained for the average cohort member from the offer of screening (intention-to-treat style of analysis) | Quality-adjusted healthy months of life gained for those who respond to the screening offer and commence treatment* | ||
|---|---|---|---|---|
Non-Māori | Māori | Non-Māori | Māori | |
>20% | 3.5 (5.2) | 2.9 (4.1) | 4.9 (7.3) | 4.1 (5.8) |
>15, ≤20% | 2.4 (3.7) | 2.1 (3.1) | 3.4 (5.3) | 3.0 (4.4) |
>10, ≤15% | 1.6 (2.6) | 1.5 (2.2) | 2.3 (3.6) | 2.1 (3.1) |
>5, ≤10% | 0.8 (1.4) | 0.9 (1.3) | 1.2 (1.9) | 1.2 (1.9) |
>0, ≤5% | 0.4 (0.7) | 0.5 (0.7) | 0.6 (1.0) | 0.7 (1.0) |
